|
Akeso, Inc. (9926.HK) DCF -Bewertung
CN | Healthcare | Biotechnology | HKSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Akeso, Inc. (9926.HK) Bundle
Bewerten Sie die finanziellen Aussichten von Akeso, Inc. mit Fachwissen! Dieser (9926HK) DCF-Taschenrechner bietet vorgefüllte Finanzdaten sowie die Flexibilität, das Umsatzwachstum, die WACC, die Margen und andere kritische Annahmen zu ändern, um sich an Ihren Projektionen anzupassen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.7 | .0 | 240.9 | 894.5 | 4,833.2 | 6,041.4 | 7,551.8 | 9,439.8 | 11,799.7 | 14,749.6 |
| Revenue Growth, % | 0 | -100 | 0 | 271.26 | 440.35 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | -298.5 | -1,076.4 | -1,405.6 | -1,359.5 | 2,319.6 | -1,836.7 | -2,295.9 | -2,869.8 | -3,587.3 | -4,484.1 |
| EBITDA, % | -394.36 | 100 | -583.41 | -151.99 | 47.99 | -30.4 | -30.4 | -30.4 | -30.4 | -30.4 |
| Depreciation | 17.6 | 16.7 | 62.2 | 113.0 | 152.4 | 1,992.0 | 2,490.1 | 3,112.6 | 3,890.7 | 4,863.4 |
| Depreciation, % | 23.27 | 100 | 25.81 | 12.63 | 3.15 | 32.97 | 32.97 | 32.97 | 32.97 | 32.97 |
| EBIT | -316.1 | -1,093.0 | -1,467.8 | -1,472.4 | 2,167.1 | -1,874.8 | -2,343.5 | -2,929.4 | -3,661.7 | -4,577.1 |
| EBIT, % | -417.63 | 100 | -609.22 | -164.62 | 44.84 | -31.03 | -31.03 | -31.03 | -31.03 | -31.03 |
| Total Cash | 1,268.4 | 2,986.1 | 2,824.8 | 2,446.5 | 2,560.2 | 5,473.2 | 6,841.5 | 8,551.9 | 10,689.9 | 13,362.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 108.8 | 289.4 | 315.6 | 2,223.6 | 2,779.5 | 3,474.4 | 4,343.0 | 5,428.7 |
| Account Receivables, % | 0 | 100 | 45.14 | 32.36 | 6.53 | 36.81 | 36.81 | 36.81 | 36.81 | 36.81 |
| Inventories | 16.6 | 65.4 | 210.0 | 365.0 | 418.4 | 3,123.6 | 3,904.4 | 4,880.6 | 6,100.7 | 7,625.9 |
| Inventories, % | 21.9 | 100 | 87.14 | 40.81 | 8.66 | 51.7 | 51.7 | 51.7 | 51.7 | 51.7 |
| Accounts Payable | 45.8 | 120.2 | 220.3 | 329.9 | 378.9 | 3,585.2 | 4,481.6 | 5,602.0 | 7,002.4 | 8,753.1 |
| Accounts Payable, % | 60.56 | 100 | 91.44 | 36.88 | 7.84 | 59.34 | 59.34 | 59.34 | 59.34 | 59.34 |
| Capital Expenditure | -145.5 | -474.4 | -760.4 | -828.2 | -939.1 | -3,770.2 | -4,712.7 | -5,890.9 | -7,363.7 | -9,204.6 |
| Capital Expenditure, % | -192.26 | 100 | -315.62 | -92.6 | -19.43 | -62.41 | -62.41 | -62.41 | -62.41 | -62.41 |
| Tax Rate, % | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 | -4.42 |
| EBITAT | -257.1 | -857.8 | -1,254.0 | -1,209.6 | 2,262.8 | -1,602.6 | -2,003.2 | -2,504.0 | -3,130.0 | -3,912.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -355.7 | -1,289.9 | -2,105.5 | -2,151.1 | 1,445.5 | -4,787.5 | -4,666.4 | -5,833.0 | -7,291.2 | -9,114.0 |
| WACC, % | 6.85 | 6.85 | 6.86 | 6.86 | 6.9 | 6.86 | 6.86 | 6.86 | 6.86 | 6.86 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -25,475.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -9,296 | |||||||||
| Terminal Value | -191,091 | |||||||||
| Present Terminal Value | -137,109 | |||||||||
| Enterprise Value | -162,584 | |||||||||
| Net Debt | -1,122 | |||||||||
| Equity Value | -161,462 | |||||||||
| Diluted Shares Outstanding, MM | 838 | |||||||||
| Equity Value Per Share | -192.72 |
What You Will Get
- Authentic Akeso Data: Comprehensive financials – from revenue to EBIT – derived from actual and forecasted figures.
- Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Akeso’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Genuine Akeso Financials: Gain access to precise pre-loaded historical data and future forecasts.
- Adjustable Forecast Assumptions: Modify yellow-highlighted cells, including WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow analysis.
- Visual Analytics Dashboard: User-friendly charts and summaries to help visualize your valuation findings.
- Designed for All Levels: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.
How It Functions
- Step 1: Download the prebuilt Excel template containing Akeso’s data.
- Step 2: Navigate through the pre-populated sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Immediately view the updated results, including Akeso’s intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the generated outputs.
Why Opt for This Calculator?
- Reliable Data: Accurate financial information from Akeso, Inc. guarantees dependable valuation outcomes.
- Flexible: Tailor essential factors such as growth rates, WACC, and tax rates to align with your forecasts.
- Efficiency-Boosting: Built-in calculations save you the hassle of starting from the ground up.
- Professional Quality: Crafted for investors, analysts, and consultants who demand excellence.
- Easy to Use: User-friendly design and clear, step-by-step guidance make it accessible for everyone.
Who Can Benefit from Akeso, Inc. (9926HK)?
- Investors: Gain insights to make informed investment choices with a top-tier valuation resource.
- Financial Analysts: Increase efficiency with a customizable DCF model that's ready to use.
- Consultants: Easily modify the template for impactful client presentations or detailed reports.
- Finance Enthusiasts: Enhance your understanding of valuation strategies through practical, real-world scenarios.
- Educators and Students: Utilize this as a valuable educational tool in finance-focused studies.
Contents of the Template
- Historical Data: Comprehensive overview of Akeso, Inc.'s (9926HK) previous financials and foundational forecasts.
- DCF and Levered DCF Models: Detailed frameworks for calculating the intrinsic value of Akeso, Inc. (9926HK).
- WACC Sheet: Pre-defined calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust critical variables such as growth rates, EBITDA percentages, and CAPEX assumptions.
- Quarterly and Annual Statements: Thorough analysis of Akeso, Inc.'s (9926HK) financial performance.
- Interactive Dashboard: Visualize valuation results and projections in an engaging manner.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.